Selected research
Market Analysis & Forecast
Global Antiemetics Market Analysis and Forecast 2026-2032
Market perspective
The global Antiemetics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antiemetics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Antiemetics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Antiemetics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Antiemetics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Antiemetics include Johnson & Johnson, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, Sanofi Aventis, Bristol Myers Squibb and Astellas, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Antiemetics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Antiemetics, also provides the sales of main regions and countries. Of the upcoming market potential for Antiemetics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiemetics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antiemetics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antiemetics sales, projected growth trends, production technology, application and end-user industry.
Antiemetics Segment by Company
Johnson & Johnson
Merck
Eli Lilly
Pfizer
GlaxoSmithKline
Baxter
Sanofi Aventis
Bristol Myers Squibb
Astellas
Antiemetics Segment by Type
Steroids
Antihistamines (H1 histamine receptor antagonists)
Anticholinergics
Dopamine antagonists
Cannabinoids
Benzodiazepines
NK1 receptor antagonist
5-HT3 receptor antagonists
Others
Antiemetics Segment by Application
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Others
Antiemetics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiemetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiemetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiemetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antiemetics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antiemetics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiemetics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Steroids
- Antihistamines (H1 histamine receptor antagonists)
- Anticholinergics
- Dopamine antagonists
- Cannabinoids
- Benzodiazepines
- NK1 receptor antagonist
- 5-HT3 receptor antagonists
- Others
Applications
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
Companies covered
- Johnson & Johnson
- Merck
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Baxter
- Sanofi Aventis
- Bristol Myers Squibb
- Astellas
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Antiemetics Market by Type
- 1.2.1 Global Antiemetics Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Steroids
- 1.2.3 Antihistamines (H1 histamine receptor antagonists)
- 1.2.4 Anticholinergics
- 1.2.5 Dopamine antagonists
- 1.2.6 Cannabinoids
- 1.2.7 Benzodiazepines
- 1.2.8 NK1 receptor antagonist
- 1.2.9 5-HT3 receptor antagonists
- 1.2.10 Others
- 1.3 Antiemetics Market by Application
- 1.3.1 Global Antiemetics Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Retail Pharmacy
- 1.3.3 Online Pharmacy
- 1.3.4 Hospital Pharmacy
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Antiemetics Market Dynamics
- 2.1 Antiemetics Industry Trends
- 2.2 Antiemetics Industry Drivers
- 2.3 Antiemetics Industry Opportunities and Challenges
- 2.4 Antiemetics Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Antiemetics Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Antiemetics Revenue by Region
- 3.2.1 Global Antiemetics Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Antiemetics Revenue by Region (2021-2026)
- 3.2.3 Global Antiemetics Revenue by Region (2027-2032)
- 3.2.4 Global Antiemetics Revenue Market Share by Region (2021-2032)
- 3.3 Global Antiemetics Sales Estimates and Forecasts 2021-2032
- 3.4 Global Antiemetics Sales by Region
- 3.4.1 Global Antiemetics Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Antiemetics Sales by Region (2021-2026)
- 3.4.3 Global Antiemetics Sales by Region (2027-2032)
- 3.4.4 Global Antiemetics Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Antiemetics Revenue by Manufacturers
- 4.1.1 Global Antiemetics Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Antiemetics Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Antiemetics Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Antiemetics Sales by Manufacturers
- 4.2.1 Global Antiemetics Sales by Manufacturers (2021-2026)
- 4.2.2 Global Antiemetics Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Antiemetics Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Antiemetics Sales Price by Manufacturers (2021-2026)
- 4.4 Global Antiemetics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Antiemetics Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Antiemetics Manufacturers, Product Type & Application
- 4.7 Global Antiemetics Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Antiemetics Market CR5 and HHI
- 4.8.2 2025 Antiemetics Tier 1, Tier 2, and Tier 3
5 Antiemetics Market by Type
- 5.1 Global Antiemetics Revenue by Type
- 5.1.1 Global Antiemetics Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Antiemetics Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Antiemetics Revenue Market Share by Type (2021-2032)
- 5.2 Global Antiemetics Sales by Type
- 5.2.1 Global Antiemetics Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Antiemetics Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Antiemetics Sales Market Share by Type (2021-2032)
- 5.3 Global Antiemetics Price by Type
6 Antiemetics Market by Application
- 6.1 Global Antiemetics Revenue by Application
- 6.1.1 Global Antiemetics Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Antiemetics Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Antiemetics Revenue Market Share by Application (2021-2032)
- 6.2 Global Antiemetics Sales by Application
- 6.2.1 Global Antiemetics Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Antiemetics Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Antiemetics Sales Market Share by Application (2021-2032)
- 6.3 Global Antiemetics Price by Application
7 Company Profiles
- 7.1 Johnson & Johnson
- 7.1.1 Johnson & Johnson Company Information
- 7.1.2 Johnson & Johnson Business Overview
- 7.1.3 Johnson & Johnson Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Johnson & Johnson Antiemetics Product Portfolio
- 7.1.5 Johnson & Johnson Recent Developments
- 7.2 Merck
- 7.2.1 Merck Company Information
- 7.2.2 Merck Business Overview
- 7.2.3 Merck Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck Antiemetics Product Portfolio
- 7.2.5 Merck Recent Developments
- 7.3 Eli Lilly
- 7.3.1 Eli Lilly Company Information
- 7.3.2 Eli Lilly Business Overview
- 7.3.3 Eli Lilly Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Eli Lilly Antiemetics Product Portfolio
- 7.3.5 Eli Lilly Recent Developments
- 7.4 Pfizer
- 7.4.1 Pfizer Company Information
- 7.4.2 Pfizer Business Overview
- 7.4.3 Pfizer Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Pfizer Antiemetics Product Portfolio
- 7.4.5 Pfizer Recent Developments
- 7.5 GlaxoSmithKline
- 7.5.1 GlaxoSmithKline Company Information
- 7.5.2 GlaxoSmithKline Business Overview
- 7.5.3 GlaxoSmithKline Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 GlaxoSmithKline Antiemetics Product Portfolio
- 7.5.5 GlaxoSmithKline Recent Developments
- 7.6 Baxter
- 7.6.1 Baxter Company Information
- 7.6.2 Baxter Business Overview
- 7.6.3 Baxter Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Baxter Antiemetics Product Portfolio
- 7.6.5 Baxter Recent Developments
- 7.7 Sanofi Aventis
- 7.7.1 Sanofi Aventis Company Information
- 7.7.2 Sanofi Aventis Business Overview
- 7.7.3 Sanofi Aventis Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Sanofi Aventis Antiemetics Product Portfolio
- 7.7.5 Sanofi Aventis Recent Developments
- 7.8 Bristol Myers Squibb
- 7.8.1 Bristol Myers Squibb Company Information
- 7.8.2 Bristol Myers Squibb Business Overview
- 7.8.3 Bristol Myers Squibb Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Bristol Myers Squibb Antiemetics Product Portfolio
- 7.8.5 Bristol Myers Squibb Recent Developments
- 7.9 Astellas
- 7.9.1 Astellas Company Information
- 7.9.2 Astellas Business Overview
- 7.9.3 Astellas Antiemetics Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Astellas Antiemetics Product Portfolio
- 7.9.5 Astellas Recent Developments
8 North America
- 8.1 North America Antiemetics Market Size by Type
- 8.1.1 North America Antiemetics Revenue by Type (2021-2032)
- 8.1.2 North America Antiemetics Sales by Type (2021-2032)
- 8.1.3 North America Antiemetics Price by Type (2021-2032)
- 8.2 North America Antiemetics Market Size by Application
- 8.2.1 North America Antiemetics Revenue by Application (2021-2032)
- 8.2.2 North America Antiemetics Sales by Application (2021-2032)
- 8.2.3 North America Antiemetics Price by Application (2021-2032)
- 8.3 North America Antiemetics Market Size by Country
- 8.3.1 North America Antiemetics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Antiemetics Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Antiemetics Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Antiemetics Market Size by Type
- 9.1.1 Europe Antiemetics Revenue by Type (2021-2032)
- 9.1.2 Europe Antiemetics Sales by Type (2021-2032)
- 9.1.3 Europe Antiemetics Price by Type (2021-2032)
- 9.2 Europe Antiemetics Market Size by Application
- 9.2.1 Europe Antiemetics Revenue by Application (2021-2032)
- 9.2.2 Europe Antiemetics Sales by Application (2021-2032)
- 9.2.3 Europe Antiemetics Price by Application (2021-2032)
- 9.3 Europe Antiemetics Market Size by Country
- 9.3.1 Europe Antiemetics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Antiemetics Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Antiemetics Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Antiemetics Market Size by Type
- 10.1.1 China Antiemetics Revenue by Type (2021-2032)
- 10.1.2 China Antiemetics Sales by Type (2021-2032)
- 10.1.3 China Antiemetics Price by Type (2021-2032)
- 10.2 China Antiemetics Market Size by Application
- 10.2.1 China Antiemetics Revenue by Application (2021-2032)
- 10.2.2 China Antiemetics Sales by Application (2021-2032)
- 10.2.3 China Antiemetics Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Antiemetics Market Size by Type
- 11.1.1 Asia Antiemetics Revenue by Type (2021-2032)
- 11.1.2 Asia Antiemetics Sales by Type (2021-2032)
- 11.1.3 Asia Antiemetics Price by Type (2021-2032)
- 11.2 Asia Antiemetics Market Size by Application
- 11.2.1 Asia Antiemetics Revenue by Application (2021-2032)
- 11.2.2 Asia Antiemetics Sales by Application (2021-2032)
- 11.2.3 Asia Antiemetics Price by Application (2021-2032)
- 11.3 Asia Antiemetics Market Size by Country
- 11.3.1 Asia Antiemetics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Antiemetics Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Antiemetics Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Antiemetics Market Size by Type
- 12.1.1 SAMEA Antiemetics Revenue by Type (2021-2032)
- 12.1.2 SAMEA Antiemetics Sales by Type (2021-2032)
- 12.1.3 SAMEA Antiemetics Price by Type (2021-2032)
- 12.2 SAMEA Antiemetics Market Size by Application
- 12.2.1 SAMEA Antiemetics Revenue by Application (2021-2032)
- 12.2.2 SAMEA Antiemetics Sales by Application (2021-2032)
- 12.2.3 SAMEA Antiemetics Price by Application (2021-2032)
- 12.3 SAMEA Antiemetics Market Size by Country
- 12.3.1 SAMEA Antiemetics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Antiemetics Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Antiemetics Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Antiemetics Value Chain Analysis
- 13.1.1 Antiemetics Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Antiemetics Production Mode & Process
- 13.2 Antiemetics Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Antiemetics Distributors
- 13.2.3 Antiemetics Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst